DrugDashboards

Market view

rifapentine · Tablet, Film Coated

2 marketed package NDCs · 2 active manufacturers

Most dispensed: 150 mg · Tablet, Film Coated · #3 blister packs/carton / 8 tablet, film coated in 1 blister pack

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price has held steady around $4.82 per unit over the past year. A shortage here was resolved within the past year — markets usually stay tight for a while after.

Price range and competition

RSS: changes for this drug

Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.

$0$2.00$4.00$6.00Nov 2019Sep 202602companies actively selling

Latest · Sep 2026 — typical price $4.82 · middle half $4.82$4.82 · full range $4.82$4.82 · 1 products · 2 companies

middle half of companies’ pricestypical (median) pricecompanies actively selling (bottom lane)Priced per unitSource: CMS NADAC
ⓘ How this was built
Data sources
  • CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
  • CMS Federal Upper Limit files (weighted AMP)
  • FDA NDC Directory (openFDA) — maker roster
Method

Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

What changed in the last 90 days

Every detected change for rifapentine, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • PriftinAug 19, 2026
    Price down
    NADAC $4.82644 → $4.82488 per unit (-0.03%)
  • PriftinAug 7, 2026
    Resolvedby this manufacturer
    Sanofi-Aventis U.S. LLC's Priftin (Tablet, Film Coated, 150 mg) is out of shortage4 companies market priftin
  • PriftinJul 22, 2026
    Price up
    NADAC $4.82112 → $4.82644 per unit (+0.11%)

Same drug class

Other molecules FDA puts in Rifamycin Antimycobacterial, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Rifapentine in shortage right now?
No. FDA does not currently list Rifapentine in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Rifapentine?
4 companies have marketed Rifapentine in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Rifapentine cost?
The typical pharmacy pays about $4.82 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

Shortage reports for this molecule

  • Shortage endedPriftin, Tablet, Film Coated, 150 mg (NDC 0088-2102-24)Mar 25, 2020

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.